Overview Financials News + Filings Key Docs Ownership Insiders
|
Tarsus Pharmaceuticals, Inc.
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Source | Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.1 | 0.3 | 0.0 | 0.0 | |
|
Returns on Capital |
ROIC (excluding intangibles) | -85.2% | -211.8% | -580.3% | -355.8% | |
ROIC (including intangibles) | -44.0% | -261.7% | -393.4% | -175.9% | |
ROE | -32.9% | -7.3% | -16.3% | -7.5% | |
ROA | -27.9% | -6.8% | -15.7% | -7.4% | |
|
Cash Conversion Cycle |
Days sales outstanding | 0.0 | 0.0 | | | 0.0 |
Cash conversion cycle | 0.0 | | | | 0.0 |
|